Novartis found to be in breach of code over drug brochure

BMJ 2013; 346 doi: (Published 21 June 2013) Cite this as: BMJ 2013;346:f4061
  1. Jacqui Wise
  1. 1London

Novartis has been found to have made several breaches of the drug advertising code of practice over a brochure promoting a new drug for chronic obstructive pulmonary disease (COPD).1

The Drug and Therapeutics Bulletin made several specific complaints about the evidence used and the claims made in …

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial